| Product Code: ETC6097807 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Angola Lung Transplant Therapeutics Market Overview |
3.1 Angola Country Macro Economic Indicators |
3.2 Angola Lung Transplant Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Angola Lung Transplant Therapeutics Market - Industry Life Cycle |
3.4 Angola Lung Transplant Therapeutics Market - Porter's Five Forces |
3.5 Angola Lung Transplant Therapeutics Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Angola Lung Transplant Therapeutics Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Angola Lung Transplant Therapeutics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.8 Angola Lung Transplant Therapeutics Market Revenues & Volume Share, By Technique, 2021 & 2031F |
3.9 Angola Lung Transplant Therapeutics Market Revenues & Volume Share, By Patient Demographics, 2021 & 2031F |
4 Angola Lung Transplant Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of lung diseases in Angola |
4.2.2 Growing awareness about lung transplants as a treatment option |
4.2.3 Advances in medical technology and surgical techniques |
4.3 Market Restraints |
4.3.1 Limited availability of donor lungs for transplants |
4.3.2 High cost associated with lung transplants and post-operative care |
4.3.3 Lack of skilled healthcare professionals and infrastructure for lung transplant procedures in Angola |
5 Angola Lung Transplant Therapeutics Market Trends |
6 Angola Lung Transplant Therapeutics Market, By Types |
6.1 Angola Lung Transplant Therapeutics Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Angola Lung Transplant Therapeutics Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Angola Lung Transplant Therapeutics Market Revenues & Volume, By Immunosuppressant Drugs, 2021- 2031F |
6.1.4 Angola Lung Transplant Therapeutics Market Revenues & Volume, By Organ Preservation Products, 2021- 2031F |
6.1.5 Angola Lung Transplant Therapeutics Market Revenues & Volume, By Tissue Products, 2021- 2031F |
6.2 Angola Lung Transplant Therapeutics Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Angola Lung Transplant Therapeutics Market Revenues & Volume, By Chronic Obstructive Pulmonary Diseases (COPD), 2021- 2031F |
6.2.3 Angola Lung Transplant Therapeutics Market Revenues & Volume, By Pulmonary Fibrosis, 2021- 2031F |
6.2.4 Angola Lung Transplant Therapeutics Market Revenues & Volume, By Septic Lung Disease, 2021- 2031F |
6.2.5 Angola Lung Transplant Therapeutics Market Revenues & Volume, By Pulmonary Hypertension, 2021- 2031F |
6.2.6 Angola Lung Transplant Therapeutics Market Revenues & Volume, By Cystic Fibrosis, 2021- 2031F |
6.2.7 Angola Lung Transplant Therapeutics Market Revenues & Volume, By Interstitial Pulmonary Fibrosis, 2021- 2031F |
6.2.8 Angola Lung Transplant Therapeutics Market Revenues & Volume, By Sarcoidosis, 2021- 2031F |
6.2.9 Angola Lung Transplant Therapeutics Market Revenues & Volume, By Sarcoidosis, 2021- 2031F |
6.3 Angola Lung Transplant Therapeutics Market, By Type |
6.3.1 Overview and Analysis |
6.3.2 Angola Lung Transplant Therapeutics Market Revenues & Volume, By Cadaveric Lung Transplantation, 2021- 2031F |
6.3.3 Angola Lung Transplant Therapeutics Market Revenues & Volume, By Living Lung Transplantation, 2021- 2031F |
6.4 Angola Lung Transplant Therapeutics Market, By Technique |
6.4.1 Overview and Analysis |
6.4.2 Angola Lung Transplant Therapeutics Market Revenues & Volume, By Single-Lung Transplantation, 2021- 2031F |
6.4.3 Angola Lung Transplant Therapeutics Market Revenues & Volume, By Bilateral-Lung Transplantation, 2021- 2031F |
6.4.4 Angola Lung Transplant Therapeutics Market Revenues & Volume, By Heart-Lung Transplantation, 2021- 2031F |
6.4.5 Angola Lung Transplant Therapeutics Market Revenues & Volume, By Double Lung Transplantation, 2021- 2031F |
6.5 Angola Lung Transplant Therapeutics Market, By Patient Demographics |
6.5.1 Overview and Analysis |
6.5.2 Angola Lung Transplant Therapeutics Market Revenues & Volume, By Geriatric, 2021- 2031F |
6.5.3 Angola Lung Transplant Therapeutics Market Revenues & Volume, By Adult, 2021- 2031F |
6.5.4 Angola Lung Transplant Therapeutics Market Revenues & Volume, By Paediatric, 2021- 2031F |
7 Angola Lung Transplant Therapeutics Market Import-Export Trade Statistics |
7.1 Angola Lung Transplant Therapeutics Market Export to Major Countries |
7.2 Angola Lung Transplant Therapeutics Market Imports from Major Countries |
8 Angola Lung Transplant Therapeutics Market Key Performance Indicators |
8.1 Average waiting time for lung transplants in Angola |
8.2 Success rate of lung transplant surgeries in the country |
8.3 Number of hospitals equipped to perform lung transplants in Angola |
9 Angola Lung Transplant Therapeutics Market - Opportunity Assessment |
9.1 Angola Lung Transplant Therapeutics Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Angola Lung Transplant Therapeutics Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Angola Lung Transplant Therapeutics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.4 Angola Lung Transplant Therapeutics Market Opportunity Assessment, By Technique, 2021 & 2031F |
9.5 Angola Lung Transplant Therapeutics Market Opportunity Assessment, By Patient Demographics, 2021 & 2031F |
10 Angola Lung Transplant Therapeutics Market - Competitive Landscape |
10.1 Angola Lung Transplant Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Angola Lung Transplant Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here